Someone’s sitting in the shade today because someone planted a tree a long time ago. - Warren Buffett
Writing about antibiotic innovators is a quandary for me because I have to balance between the need for investment profits for investors vs. my social responsibility. It's an interesting phenomenon that antibiotic developers like Melinta Therapeutics (MLNT) is launching stellar medicines but the company has yet to bank any profit. Another firm, Achaogen (AKAO), recently gained the approval of Zemdri only to suffer from a Chapter 11 reorganization. Instead of financially rewarding innovators